Marshall Urist - Net Worth and Insider Trading
Marshall Urist Net Worth
The estimated net worth of Marshall Urist is at least $2 Million dollars as of 2024-11-10. Marshall Urist is the EVP, Research & Investments of Royalty Pharma PLC and owns about 65,687 shares of Royalty Pharma PLC (RPRX) stock worth over $2 Million. Details can be seen in Marshall Urist's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Marshall Urist has not made any transactions after 2023-02-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Marshall Urist
Marshall Urist Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Marshall Urist owns 1 companies in total, including Royalty Pharma PLC (RPRX) .
Click here to see the complete history of Marshall Urist’s form 4 insider trades.
Insider Ownership Summary of Marshall Urist
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RPRX | Royalty Pharma PLC | 2023-02-22 | EVP & Research & Investments |
Marshall Urist Latest Holdings Summary
Marshall Urist currently owns a total of 1 stock. Marshall Urist owns 65,687 shares of Royalty Pharma PLC (RPRX) as of February 22, 2023, with a value of $2 Million.
Latest Holdings of Marshall Urist
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RPRX | Royalty Pharma PLC | 2023-02-22 | 65,687 | 26.21 | 1,721,656 |
Holding Weightings of Marshall Urist
Marshall Urist Form 4 Trading Tracker
According to the SEC Form 4 filings, Marshall Urist has made a total of 6 transactions in Royalty Pharma PLC (RPRX) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Royalty Pharma PLC is the sale of 23,333 shares on February 22, 2023, which brought Marshall Urist around $870,321.
Insider Trading History of Marshall Urist
- 1
Marshall Urist Trading Performance
Marshall Urist Ownership Network
Ownership Network List of Marshall Urist
Ownership Network Relation of Marshall Urist
Marshall Urist Owned Company Details
What does Royalty Pharma PLC do?
Who are the key executives at Royalty Pharma PLC?
Marshall Urist is the EVP & Research & Investments of Royalty Pharma PLC. Other key executives at Royalty Pharma PLC include 10 percent owner Avara Management Ltd , EVP & CFO Terrance P. Coyne , and director & CEO & Chairman of the Board Pablo G. Legorreta .
Royalty Pharma PLC (RPRX) Insider Trades Summary
Over the past 18 months, Marshall Urist made no insider transaction in Royalty Pharma PLC (RPRX). Other recent insider transactions involving Royalty Pharma PLC (RPRX) include a net purchase of 600,000 shares made by Pablo G. Legorreta , a net sale of 934,197 shares made by Avara Management Ltd , and a net sale of 2,220,000 shares made by Rory B Riggs .
In summary, during the past 3 months, insiders sold 0 shares of Royalty Pharma PLC (RPRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,496,418 shares of Royalty Pharma PLC (RPRX) were sold and 600,000 shares were bought by its insiders, resulting in a net sale of 2,896,418 shares.
Royalty Pharma PLC (RPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Royalty Pharma PLC Insider Transactions
Marshall Urist Mailing Address
Above is the net worth, insider trading, and ownership report for Marshall Urist. You might contact Marshall Urist via mailing address: C/o Royalty Pharma Plc, 110 East 59th Street, New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
